Covance, MIT’s tenant at The Synergy building recently celebrated the expansion of its central laboratory facility in Singapore which will enhance the company's current service offerings and position it to meet current and future growth of drug development in the Asia Pacific region.
Covance is a leading provider of drug development services, with more than 11,000 employees in 60 countries, helping pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.
The expansion is the latest in Covance's continued investment in Singapore, and an important element of the strategic investment plans for the Asia Pacific region that also includes recent growth in operations in China and Japan.
The laboratory, at approximately 2,700 square meters (29,000 square feet), is the largest of its kind in Singapore, providing clinical testing services to clients in Asia, including South Korea, Taiwan, Hong Kong, the Philippines, Australia, and India. This laboratory expansion doubles the size of Covance's genomics footprint in Singapore, while also adding capabilities in anatomic pathology and nutritional chemistry. The Singapore facility continues to provide a full-service offering that includes chemistry, immunology, hematology, flow cytometry, genomics, anatomic pathology, and microbiology.
Covance’s expansion further strengthens The Synergy building as a research and development cluster. The Synergy is a modern business park comprising a 10-storey tower building with a five-storey podium located within International Business Park in the west. Approximately 14 km from the city centre, The Synergy is accessible via the AYE and the PIE. It enjoys convenience with Jurong East MRT station and Jurong East Bus Interchange located nearby. The building provides ready-built business park space with a fully air-conditioned environment, 24-hour security services and a fully automated electronic parking system.
For enquiries regarding leasing of space at The Synergy, please call 6377 8000.